Page last updated: 2024-12-05

1,1,3,3-tetramethylurea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,1,3,3-Tetramethylurea (TMU) is a cyclic organic compound with the formula (CH3)2NC(O)N(CH3)2. It is a colorless, hygroscopic liquid with a characteristic ammoniacal odor. It is commonly used as a solvent and a reagent in organic chemistry. TMU is a strong hydrogen bond acceptor, making it an effective solvent for a wide range of organic compounds. It is also a useful reagent for the synthesis of amides, ureas, and other nitrogen-containing compounds. TMU has been studied for its potential applications in various fields, including:
* **Catalysis**: TMU can act as a catalyst in various organic reactions, such as the Diels-Alder reaction.
* **Material Science**: It has been investigated as a precursor for the synthesis of polymers and other materials.
* **Medicine**: TMU has shown some biological activity, including anti-inflammatory and antimicrobial effects. It has also been explored as a potential drug delivery system.
* **Agriculture**: TMU has been studied for its potential use as a fertilizer and a plant growth regulator.'

1,1,3,3-tetramethylurea: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,1,3,3-tetramethylurea : A member of the class of ureas that is urea substituted by methyl groups at positions 1, 1, 3 and 3 respectively. Metabolite observed in cancer metabolism. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12437
CHEMBL ID11949
CHEBI ID84278
SCHEMBL ID24760
MeSH IDM0045144

Synonyms (55)

Synonym
tetramethyluree
2o1ej64031 ,
4-04-00-00225 (beilstein handbook reference)
unii-2o1ej64031
temur
TMU ,
1,1,3,3-tetramethylurea
nsc91488
nsc-91488
tetramethyl urea
wln: 1n1&vn1&1
urea,1,3,3-tetramethyl-
1,3,3-tetramethylurea
urea, tetramethyl-
n,n,n',n'-tetramethylurea
tetramethylurea
urea, n,n,n',n'-tetramethyl-
632-22-4
inchi=1/c5h12n2o/c1-6(2)5(8)7(3)4/h1-4h
urea,1,1,3,3-tetramethyl
tetramethylurea, 99%
tetramethyluree [french]
einecs 211-173-9
ai3-50988
hsdb 129
nsc 91488
urea, 1,1,3,3-tetramethyl-
brn 0773898
CHEMBL11949
tetramethyl-urea
chebi:84278 ,
T0158
A834282
AKOS015918289
FT-0606008
tetramethylcarbamide
tetramethylurea [hsdb]
tetramethylurea [mi]
tetramethylurea, 1,1,3,3-
n,n,n',n',-tetramethyl urea
n,n,n',n'-tetramethyl urea
SCHEMBL24760
n,n,n',n'-tetramethyl-urea
DTXSID1060893
((ch3)2n)2co
W-104925
mfcd00008319
F0001-1719
tetramethylurea, >=99.5% (gc)
tetramethylurea, bcr(r) certified reference material
CS-0011002
Q26699773
D70479
tetramethylurea 1,1,3,3-tetramethylurea
EN300-108206

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Thus, TMU was not considered to be uniquely toxic to the rat conceptus."( Developmental toxicity study of tetramethylurea (TMU) in rats.
Hurtt, ME; Kennedy, GL; Munley, SM; O'Neill, AJ; Tyler, DL, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ureas
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID71775Percent of untreated control cell growth evaluated in friend leukemia cells on day 3 at a concentration of 4 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
AID71665Cell growth of friend erythroleukemia cells measured as percentage of control on day 6 at a concentration of 4 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
AID71654The degree of erythroid maturation was measured by assessing the proportion of benzidine-positive cells at a concentration of 4 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (32.61)18.7374
1990's7 (15.22)18.2507
2000's15 (32.61)29.6817
2010's8 (17.39)24.3611
2020's1 (2.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.97 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]